Polipharmacy in the antipsychotic prescribing in practices psychiatric out-patient clinic;Polifarmacia en la prescripción de antipsicóticos en consultas de psiquiatría

Actas Espanolas de Psiquiatria

Volumn 32, Issue 6, 2004, Pages 333-339

  Florez Menendez G ^a,c   Blanco Ramos, M ^a   Gomez Reino Rodriguez I ^a   Gayoso Diz, P ^a   Bobes Garcia J ^b  

^a UNIVERSITY OF OVIEDO   (Spain)

^b UNIVERSIDAD DE OVIEDO   (Spain)

^c NONE   (Spain)

Author keywords

Antipsychotics; Polypharmacy; Psychosis; Schizophrenia

Indexed keywords

CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL PRACTICE; MEDICAL RECORD; MENTAL DEFICIENCY; MENTAL DISEASE; OUTPATIENT DEPARTMENT; POLYPHARMACY; PSYCHOSIS; RETROSPECTIVE STUDY;

EID: 10444243267     PISSN: 11399287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Healy D. Management of the psychoses. En: Healy D, editor. Psychiatric drugs explained. England: Mosby, 1997; p. 5-48.
2. a ed. Cambridge: Cambridge University Press, 2000; p. 401-58.
3. Waddington J, Scully P, O'Callaghan. The new antipsychotics and their potential for early intervention in schizophrenia. Schizophr Res 1997;28:207-22.
4. Marder S, Essock S, Miller A, Buchanan R, Davis J, Kane J, et al. The Mount Sinai Conference on the Pharmacotherapy of Schizophrenia. Schizophr Bull 2002;28(1):5-16.
5. Covell H, Jackson C, Evans A, Essock S. Antipsychotic prescribing practices in Connecticuts public mental health system: rates of changing medications and prescribing styles. Schizophr Bull 2002;28(1):17-29.
6. Kane JM, Leucht, Carpenter D, Docherty JP. The expert consensus guideline series optimizing pharmacologic treatment of psychotic disorders. J Clin Psychiatry 2003; 64(Suppl 12):5-19.
7. Clark R, Stephen J, Mellman T, Peacock W. Recent trends in antipsychotic combination therapy of schizophrenia and schizoaffective disorder: implication for state mental health policy. Schizophr Bull 2002;28(1):75-84.
8. Nasrallah H, Smeltzer D. The new generation of atypical antipsychotics. En: Nasrallah H, Smeltzer D, editores. The patient with schizophrenia. Newtown: Handbooks in Health Care Co, 2002; p. 170-212.
9. Conley R, Buchanan R. Evaluation of treatment-resistant schizophrenia. Schizophr Bull 1997;23(4):663-74.
10. Shiloh R, Zemishlany Z, Aizenberg D, Radwan M, Schwartz B, Dorfman-Etrog P, et al. Sulpiride augmentation in people with schizophrenia partially responsive to clozapine. Br J Psychiatry 1997;171:569-73.
11. Buchanan R, Kreyenbuhl J, Zito J, Lehman A. The schizophrenia PORT pharmacological treatment recommendations: conformance and implications for symptoms and functional outcome. Schizophr Bull 2002;28(1):63-73.
12. Tandon R, Jibson M, Marder S, Goldman M, Glick I, Mellman T. Issues in pharmacotherapy of schizophrenia. Tandon R, editor. New York: McMahon Publishing Group, 2002; p. 16-25.
13. Yorston G, Pinney A. Chlorpromazine equivalents and the percentage of BNF maximum dose in patients receiving high-dose antipsychotics. Psychiatr Bull 2000;24:130-2.
14. Weissman E. Antipsychotic prescribing practices in the veterans healthcare administration. New York: Metropolitan Region. Schizophr Bull 2002;28(1):31-42.
15. Freudenreich O, Goff D. Antipsychotic combination therapy in schizophrenia. A review of efficacy and risks of current combinations. Act Psychiatr Scand 2002;106:323-30.
16. Jones H, Pilowsky L. Dopamine and antipsychotic drug action revisited. Br J Psychiatry 2002;181:271-5.
17. Kane J, et al. Clozapine for the treatment-resistant schizophrenic a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988;45:789-96.
18. Van Putten T, Marder S, Wirshing S, Aravagiri M, Chabert N. Neuroleptic plasma levels. Schizophr Bull 1991;17(2): 197-216.
19. Herz M, Lamberti S, Mintz J, Scott R, O'Dell, McCartan L, et al. A program for relapse prevention in schizophrenia. Arch Gen Psychiatry 2000;57:277-83.
20. Gottesman I. Schizophrenia across time and space. Gottesman I, editor. Schizophrenia genesis. New York: Freeman and Co, 1992; p. 60-81.